VIROMETIX
Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. In an increasingly global world there is a considerable medical need for vaccines to combat infectious as well as a number of chronic human diseases. Fast growing demands, health threats from newly arising complex viral and bacterial pathogens and increasingly stringent requirements for stability, safet... y and tolerability require new approaches to tackling current and future challenges. Rational molecular design, chemical synthesis and Virometix' proprietary Synthetic Virus-Like Particle platform technology allow for the rapid production and optimization of vaccine candidates with superior properties in terms of safety, efficacy and stability.
VIROMETIX
Industry:
Biotechnology Health Care Medical
Founded:
2009-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.virometix.com
Total Employee:
11+
Status:
Closed
Contact:
+41 (0) 43 433 86 60
Email Addresses:
[email protected]
Total Funding:
13.71 M CHF
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Maps SSL By Default
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
BioCentrum
BioCentrum is a privately-owned biotechnology service and product provider.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Crioestaminal
Crioestaminal is a privately held biotechnology company that engages in preservation of stem cells to treat future ailments.
Cytovation
Cytovation AS is a privately-held biotech company, specialising .
Genis
Genis is a privately held biotechnology company located in Iceland.
Gubra
Gubra is a privately-held biotech company
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Investors List
Harry Welten
Harry Welten investment in Series A - Virometix
Venture Kick
Venture Kick investment in Grant - Virometix
Official Site Inspections
http://www.virometix.com Semrush global rank: 9.98 M Semrush visits lastest month: 286
- Host name: 104.21.4.27
- IP address: 104.21.4.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Virometix"
Home - Virometix AG
Virometix AG is a clinical stage biotech company pioneering a new class of synthetic vaccines to tackle infectious diseases and cancer. Our structure-based vaccines are designed to direct a precise, robust and sustained immune …See details»
Virometix - Crunchbase Company Profile & Funding
Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of …See details»
Virometix 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Virometix. Use the PitchBook Platform to explore the full profile.See details»
Virometix AG - Swiss Biotech
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic …See details»
Virometix Company Profile - Office Locations, Competitors ... - Craft
Virometix has 5 employees at their 1 location and $18.53 m in total funding,. See insights on Virometix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Virometix - Products, Competitors, Financials, Employees, …
Virometix is a clinical stage biotech company focused on developing synthetic vaccines for infectious diseases and cancer. The company has vaccines designed to elicit an immune …See details»
About us - Virometix AG
Virometix AG is a privately held Swiss biotechnology company whose purpose is the discovery and development of fully synthetic vaccines to generate targeted and protective immune responses against infectious diseases and cancer. …See details»
Virometix - VentureRadar
"Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic …See details»
Organization | Virometix
Acquisitions Trial Sponsor Other Trial Involvement2020See details»
Virometix AG - life-sciences-europe.com
Virometix AG is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infections and …See details»
Virometix - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 23, 2025 Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and …See details»
Virometix AG Company Profile | Schlieren, ZÜRICH, Switzerland ...
Find company research, competitor information, contact details & financial data for Virometix AG of Schlieren, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Virometix AG - Executive Bio, Top Executies, and Transitions
View the organization profile of Virometix AG,Markus Heck has more than 15 years of experience in the pharmaceutical and biotech industry and in regulated environments in various roles …See details»
Virometix AG - Company Profile and News - Bloomberg Markets
Company profile page for Virometix AG including stock price, company news, executives, board members, and contact informationSee details»
Virometix AG, Schlieren, Switzerland - North Data
Dec 12, 2024 Virometix AG, Schlieren, Switzerland, Schweizer Handelsregister CHE-115.105.074: Patents, Network, Financial informationSee details»
Our Platform - Virometix AG
Our growing patent portfolio includes umbrella patents granted for the SVLP platform. In addition, Virometix has established exclusive license and IPR agreements for patent rights owned by …See details»
Virometix AG - Venture Kick
Virometix AG: Virometix develops a new generation of vaccines using its Synthetic Virus-Like Particle (SVLP) technology, which enables the creation of a novel type of synthetic …See details»
Partners - Virometix AG
Our Company Virometix AG is a privately held Swiss biotechnology company whose purpose is the discovery and development of fully synthetic vaccines to generate targeted and protective …See details»
Newsroom - Virometix AG
Jul 9, 2020 Virometix AG - latest news and press releases, upcoming events, publications and presentationsSee details»
Virometix - Funding, Financials, Valuation & Investors
Virometix is funded by 2 investors. Harry Welten and Venture Kick are the most recent investors. Which investors participated in the most funding rounds?See details»